The Lancet. Infectious diseases 2023 Apr 24; . doi: 10.1016/S1473-3099(23)00269-4. Epub 2023 04 24
Publications
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2023 Apr 01; 27(4); . doi: 10.5588/ijtld.22.0678. Epub 2023 04 10
Mortality and Cause of Death in Children With Presumptive Disseminated Tuberculosis.
Abstract
BACKGROUND AND OBJECTIVES: Children experience high tuberculosis (TB)-related mortality but causes of death among those with presumptive TB are poorly documented.
Pediatrics 2023 Apr 01; 151(4); . doi: 10.1542/peds.2022-057912. Epub 2023 04 04
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Abstract
BACKGROUND: Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities every year.
PloS one 2023 ; 18(3); . doi: 10.1371/journal.pone.0283643. Epub 2023 03 30
It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda.
Abstract
Barriers continue to limit access to viral load (VL) monitoring across sub-Saharan Africa adversely impacting control of the HIV epidemic.
PLOS global public health 2023 ; 3(3); . doi: 10.1371/journal.pgph.0001678. Epub 2023 03 27
Assessment of the proportion of households with burn victims, associated risk factors and knowledge of burn injury prevention strategies in South Western Uganda. A population based cross sectional survey.
Abstract
BACKGROUND: Burn injuries are a major cause of morbidity and mortality within Low- and Middle-income countries (LMICs). Most of these burn injuries occur at home with children most at risk.
Burns : journal of the International Society for Burn Injuries 2023 Mar 24; . doi: 10.1016/j.burns.2023.03.016. Epub 2023 03 24
Adults
Burn prevention
Children
Electricity protective
Household burns
Uganda
Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads' perspective.
Abstract
BACKGROUND: Worldwide, 1.7 million children younger than 15 years were living with HIV in 2021. Only 52% of them had access to antiretrovirals (ARVs). Lack of age-appropriate ARV formulations (i.e.
Therapeutic advances in infectious disease 2023 ; 10; . doi: 10.1177/20499361231159993. Epub 2023 03 21
HIV
acceptability
antiretroviral therapy
fixed-dose combination
paediatric ARV
Protection, health seeking, or a laissez-passer: Participants' decision-making in an EVD vaccine trial in the eastern Democratic Republic of the Congo.
Abstract
During the 10th Ebola virus disease (EVD) epidemic in the eastern Democratic Republic of the Congo (DRC) (2018-2020), two experimental EVD vaccines were deployed in North Kivu.
Social science & medicine (1982) 2023 Mar 15; 323; . doi: 10.1016/j.socscimed.2023.115833. Epub 2023 03 15
Clinical trials
DRC
Ebola
Epidemics
Vaccine
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis.
Abstract
BACKGROUND: Many children with pulmonary tuberculosis remain undiagnosed and untreated with related high morbidity and mortality.
The Lancet. Child & adolescent health 2023 Mar 13; . doi: 10.1016/S2352-4642(23)00004-4. Epub 2023 03 13